Cadrenal Therapeutics, Inc. (CVKD): Operating Income
-$13.46M
Year ended 2025-12-31
-$10.19M
Trailing 12 months to 2026-09-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$13.46M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$10.96M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$7.63M | n/a | 2025-03-13, From 2023-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | -$13.46M | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | -$11.88M | n/m |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | -$5.17M | n/m |
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$267.0K | n/m |
| Azitra, Inc. (AZTR) | 2025-12-31 | -$10.97M | n/m |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | -$8.77M | n/m |
| Protagenic Therapeutics, Inc.new (PTIX) | 2026-03-31 | -$4.50M | n/m |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | -$4.64M | n/m |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | -$7.82M | n/m |
Compare CVKD, LEXX, PULM, ISCO side by side · Screen every company in Pharmaceutical Preparations ↗